Medicenna Therapeutics Corp. MDNA.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.96% | 1.40% | 11.71% | 0.46% | -530.64% |
| Total Depreciation and Amortization | 20.59% | -11.30% | -31.14% | 21.90% | 3.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.51% | -207.14% | -1,859.33% | 125.52% | 100.29% |
| Change in Net Operating Assets | -70.44% | 1,091.56% | 249.77% | -109.13% | 44.66% |
| Cash from Operations | 1.89% | 8.40% | 0.64% | -39.86% | 26.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -5.26% | 0.00% | -46.15% | 31.58% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19,285.62% | -7.35% | 1.45% | -148.94% | 313.64% |
| Foreign Exchange rate Adjustments | -105.30% | 188.26% | -161.27% | 128.26% | -527.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.28% | 13.63% | -7.67% | -8.09% | 11.97% |